东瑞制药（02348.HK）今日盘中大跌6.98%，引发市场关注。这一股价走势与公司最新发布的中期业绩报告密切相关。
根据公司公告，东瑞制药2025年上半年业绩出现明显下滑。期内，公司录得收入6.3亿元人民币，同比下降9.2%；净利润为1.05亿元人民币，同比大幅下滑78.8%。每股盈利降至0.06961元人民币。尽管业绩下滑，公司仍维持中期派息1.5港仙。
分析人士认为，东瑞制药净利润的大幅下滑是引发股价下跌的主要原因。这一业绩表现可能引发投资者对公司未来盈利能力的担忧，从而导致股价承压。市场将密切关注公司后续的经营策略调整和业绩改善措施。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.